Joslin Diabetes Center Research | Research Updates from Joslin Diabetes Center

Established in 1898, Joslin Diabetes Center is an internationally recognized diabetes treatment, research and education institution affiliated with Harvard Medical School and headquartered in Boston, MA. Joslin is a non-profit organization dedicated to finding a cure for diabetes and improving the lives of people with diabetes through its cutting edge basic and clinical research, patient care programs for children and adults, and through programs and publications that improve the care of diabetes worldwide. Some of the most important improvements in diabetes care — including treatments for diabetes in pregnancy, the development of laser surgery to treat diabetic eye disease, and the identification of markers for "pre-diabetes" — were developed at Joslin. In addition to its headquarters facility in Boston, Joslin has affiliated treatment facilities at more than 25 locations from coast to coast. Support Joslin research now.

Recent Research From Joslin

Beta Cells Need Key Protein to Divide and Conquer Diabetes

Joslin Diabetes Center and dLife Form Online Partnership

Relieving Stress on Beta Cells May Aid in Diabetes

Joslin Finds New Drug Targets for Diabetes Eye Complications

Joslin Study Identifies Gene Linked to Rare Form of Diabetes

Joslin Diabetes Center President and CEO Ranch C. Kimball to Step Down

Joslin Study Identifies ‘Good’ Energy Burning Fat in Lean Adults

Richard R. Crater Joins Joslin Diabetes Center as Chief Financial Officer

Joslin Receives $1 Million to Support Type 1 Diabetes Research

Joslin Identifies Source of Beta Cell Damage

Managing Diabetes During Pregnancy

Getting Older and Staying Healthy with Diabetes

The Heart of the Matter: Diabetes and Cardiovascular Disease

Diabetes Research: Advancing Toward a Cure

Joslin Diabetes Center Launches National Clinical Trial To Explore If Anti-Inflammatory Drug Can Improve Glucose Control in Type 2 Diabetes

New Joslin-led Study Uncovers Role of Appetite-Related Melanin Concentrating Hormone (MCH) in the Brain to Beta Cell Growth and Insulin Secretion

Joslin Researchers Discover Protein that Causes Blood Vessel Leakage in Eyes with Diabetic Retinopathy

High Blood Glucose Levels in Early Pregnancy May Deprive Embryo of Oxygen and Lead to Birth Defects, Joslin Diabetes Center Study Shows

New Imaging Technology Shown to Detect Pancreatic Inflammation in Type 1 Diabetes and Its Reversal in Animal Models

Joslin Researchers Discover New Gene for Type 2 Diabetes Using DNA Chip

Diabetes - Is it in Your Genes?

Eyes on the Prize: Preventing Vision Problems Associated With Diabetes

Not Quite An Artificial Pancreas: Insulin Pumps and Glucose Sensor Devices

Obesity: It's Gaining On Us

Last Modified Date: November 27, 2012

All content on is created and reviewed in compliance with our editorial policy.

More on this Topic

No items are associated with this tag

Sign up for FREE dLife Newsletters

dLife Membership is FREE! Get exclusive access, free recipes, newsletters, savings, and much more! FPO

You are subscribed!
You are subscribed!
You are subscribed!
2655 Views 0 comments
by Brenda Bell
As I mentioned in an earlier post, one of the benefits that made it cost-effective for me to go with the real healthcare (HSA) plan rather than the phony (HRA) plan is that my company is now covering "preventative" medicines at $0 copay. The formulary for these, as stated by CVS/Caremark (my pharmacy benefits provider), covers all test strips, lancets, and control solutions. I dutifully get my doctor to write up prescriptions for all of my testing needs, submit...
  • Watch dLifeTV online now!

    Click here for more info